Kalaris Therapeutics Inc (KLRS): Next-Year EPS Estimate 26.98%
As of 2026-05-12, Kalaris Therapeutics Inc (KLRS) has a next-year EPS growth estimate of 26.98%.
On 2026-05-12, analyst consensus for KLRS's next-year EPS growth shifted from 32.37% to 26.98% — a negative change of 5.39 percentage points. Current-year growth is projected at 32.16%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 26.98%
- EPS growth this year
- 32.16%
- EPS next quarter (est)
- -$0.48
- Last price
- $4.79
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-12 | 26.98% | 32.16% | -$0.48 | $4.79 |
| 2026-05-11 | 32.37% | 23.04% | -$0.52 | $4.73 |
| 2026-05-10 | 32.37% | 23.04% | -$0.52 | $5.08 |
| 2026-05-07 | 32.37% | 23.04% | -$0.52 | $5.15 |
| 2026-05-06 | 32.37% | 23.04% | -$0.52 | $5.06 |
| 2026-05-05 | 32.37% | 23.04% | -$0.52 | $5.30 |
| 2026-05-04 | 32.37% | 23.04% | -$0.52 | $5.53 |
| 2026-05-03 | 32.37% | 23.04% | -$0.52 | $5.46 |
| 2026-04-30 | 32.37% | 23.04% | -$0.52 | $5.52 |
| 2026-04-29 | 32.37% | 23.04% | -$0.52 | $5.51 |
| 2026-04-28 | 32.37% | 23.04% | -$0.52 | $5.64 |
| 2026-04-27 | 32.37% | 23.04% | -$0.52 | $6.02 |
| 2026-04-26 | 32.37% | 23.04% | -$0.52 | $6.11 |
| 2026-04-24 | 32.37% | 23.04% | -$0.52 | $6.11 |
| 2026-04-23 | 32.37% | 23.04% | -$0.52 | $6.10 |
| 2026-04-22 | 32.37% | 23.04% | -$0.52 | $6.33 |
| 2026-04-21 | 32.37% | 23.04% | -$0.52 | $6.28 |
| 2026-04-20 | 32.37% | 23.04% | -$0.52 | $6.60 |
| 2026-04-19 | 32.37% | 23.04% | -$0.52 | $6.32 |
| 2026-04-16 | 32.37% | 23.04% | -$0.52 | $6.59 |
| 2026-04-15 | 37.39% | 21.54% | -$0.53 | $5.87 |
| 2026-04-14 | 37.39% | 21.54% | -$0.53 | $5.82 |
| 2026-04-13 | 37.39% | 21.54% | -$0.53 | $6.31 |
| 2026-04-12 | 37.39% | 21.54% | -$0.53 | $6.30 |
| 2026-04-10 | 37.39% | 21.54% | -$0.53 | $6.19 |
| 2026-04-09 | 37.39% | 21.54% | -$0.53 | $6.07 |
| 2026-04-08 | 37.39% | N/A | -$0.53 | $6.34 |
| 2026-04-07 | 37.39% | N/A | -$0.53 | $6.46 |
| 2026-04-06 | 37.39% | N/A | -$0.53 | $6.46 |
| 2026-04-05 | 37.39% | N/A | -$0.53 | $5.79 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Kalaris Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-05-12, Kalaris Therapeutics Inc (KLRS) has a next-year EPS growth estimate of 26.98%, based on analyst consensus.
When was the latest EPS estimate revision for KLRS?▾
The most recent revision occurred on 2026-05-12, when analysts adjusted the next-year EPS growth estimate from 32.37% to 26.98%.
What sector and industry does Kalaris Therapeutics Inc belong to?▾
Kalaris Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. KLRS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Kalaris Therapeutics Inc (KLRS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports